SIREN : 904016532
GMED is a French company founded 4 years ago, specialized in the sector Activités des sièges sociaux. Based in VILLENEUVE-D'ASCQ (59493), this company of category PME shows in 2024 a revenue of 150 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 150 000 € | 150 000 € | 179 032 € |
| Net income | 97 731 € | 98 360 € | 119 408 € |
| EBITDA | 145 423 € | 144 982 € | 173 078 € |
| Net margin | 65.2% | 65.6% | 66.7% |
In 2024, GMED achieves revenue of 150 k€. Revenue is declining over the period 2022-2024 (CAGR: -8.5%). Slight decline of 0% vs 2023. After deducting consumption (0 €), gross margin stands at 150 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 145 k€, representing 96.9% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 98 k€, i.e. 65.2% of revenue. This profit can be retained or distributed to shareholders.
150 000 €
150 000 €
145 423 €
145 422 €
97 731 €
96.9%
The debt ratio (= Financial debt / Equity x 100) stands at 157%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.5 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 65.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
156.672%
38.563%
65.154%
5.506
In 2024, the debt ratio of GMED (156.67) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of GMED (38.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of GMED (5.51) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 30.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 14.3x. Operating income very largely covers interest expenses: high safety margin.
30.658
14.289
In 2024, the liquidity ratio of GMED (30.66) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of GMED (14.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 36 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 228 days. Excellent situation: suppliers finance 192 days of the operating cycle (retail model). Overall, WCR represents 25 days of revenue, i.e. 11 k€ to permanently finance. Over 2022-2024, WCR increased by +316%, requiring additional financing.
10 610 €
36 j
228 j
0 j
25 j
Based on 103 transactions of similar company sales in 2024, the value of GMED is estimated at 568 670 € (range 134 887€ - 1 139 941€). With an EBITDA of 145 423€, the sector multiple of 5.0x is applied. The price/revenue ratio is 0.38x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GMED with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of GMED in 2024 is 150 k€.
Yes, GMED generated a net profit of 98 k€ in 2024.
The headquarters of GMED is located in VILLENEUVE-D'ASCQ (59493), in the department Nord.
The tax return of GMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GMED operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.